3.8 Article

Confidentiality and trial integrity issues for adaptive designs

Journal

DRUG INFORMATION JOURNAL
Volume 40, Issue 4, Pages 445-450

Publisher

DRUG INFORMATION ASSOCIATION
DOI: 10.1177/216847900604000410

Keywords

interim analysis; Data Monitoring Committee; unblinded data; seamless design

Ask authors/readers for more resources

Adaptive design trials raise important issues regarding processes for review of interim data and implementation of adaptation decisions, while avoiding bias and maintaining interpretability of trial results. We discuss the issues, distinctions versus more familiar monitoring situations, various aspects of operational models for data monitoring and types of adaptations that may be more or less prone to concerns, about bias.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available